• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多学科临床方案可有效稳定 BMI 并降低 NAFLD 患儿的转氨酶水平。

A multidisciplinary clinical program is effective in stabilizing BMI and reducing transaminase levels in pediatric patients with NAFLD.

机构信息

Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.

出版信息

J Pediatr Gastroenterol Nutr. 2013 Jul;57(1):119-23. doi: 10.1097/MPG.0b013e318290d138.

DOI:10.1097/MPG.0b013e318290d138
PMID:23518484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3696482/
Abstract

BACKGROUND AND AIM

Weight loss is an effective treatment for children with nonalcoholic fatty liver disease (NAFLD), but it is extremely difficult to achieve outside of an intensive weight management program. We hypothesized that one can achieve success in improving NAFLD and weight-related outcomes in a structured and focused multidisciplinary clinical program feasible to implement in a gastroenterology clinic.

METHODS

We prospectively tracked the clinical status of our patients enrolled in a multidisciplinary program of dietary and exercise advice through an institutional review board-approved NAFLD registry. Each patient met with a gastroenterologist and dietitian every 3 months for 30 minutes to set individualized goals and monitor progress.

RESULTS

A total of 108 children have been enrolled in the registry, and of the 83 that were eligible for 1-year follow-up and included in the analysis, 39 patients returned, resulting in a 47% follow-up rate. These 39 patients showed statistically significant improvements in mean BMI z score (-0.1 U, P < 0.05), total (-11 mg/dL, P < 0.05) and low-density lipoprotein (9 mg/dL, P < 0.05) cholesterol, and serum alanine aminotransferase levels (-36 U/L) and aspartate aminotransferase levels (-22 U/L) levels.

CONCLUSIONS

A clinically feasible multidisciplinary program for obese pediatric patients with NAFLD stabilized BMI z score and significantly improved aminotransferase levels at 1-year follow-up.

摘要

背景与目的

减肥是治疗非酒精性脂肪性肝病(NAFLD)儿童的有效方法,但在强化体重管理方案之外,减肥非常困难。我们假设,通过一种可行的、以结构化和集中为特点的多学科临床方案,可以在改善 NAFLD 和与体重相关的结果方面取得成功。

方法

我们通过机构审查委员会批准的 NAFLD 注册中心,前瞻性地跟踪了参加多学科饮食和运动建议方案的患者的临床状况。每位患者每 3 个月与胃肠病学家和营养师会面 30 分钟,以制定个性化目标并监测进展。

结果

共有 108 名儿童被纳入该注册中心,其中 83 名符合 1 年随访条件并纳入分析,39 名患者返回,随访率为 47%。这些 39 名患者的 BMI z 评分(-0.1 U,P < 0.05)、总胆固醇(-11 mg/dL,P < 0.05)和低密度脂蛋白胆固醇(-9 mg/dL,P < 0.05)以及血清丙氨酸氨基转移酶水平(-36 U/L)和天冬氨酸氨基转移酶水平(-22 U/L)均有统计学显著改善。

结论

对于肥胖的 NAFLD 儿科患者,一种可行的临床多学科方案可稳定 BMI z 评分,并在 1 年随访时显著改善转氨酶水平。

相似文献

1
A multidisciplinary clinical program is effective in stabilizing BMI and reducing transaminase levels in pediatric patients with NAFLD.多学科临床方案可有效稳定 BMI 并降低 NAFLD 患儿的转氨酶水平。
J Pediatr Gastroenterol Nutr. 2013 Jul;57(1):119-23. doi: 10.1097/MPG.0b013e318290d138.
2
Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease.非酒精性脂肪肝患儿生活方式干预 1 年后的动脉功能和结构变化。
Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):1010-6. doi: 10.1016/j.numecd.2012.08.003. Epub 2012 Sep 24.
3
Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.肥胖儿童非酒精性脂肪肝病的生活方式干预:2年随访研究。
Arch Dis Child. 2009 Jun;94(6):437-42. doi: 10.1136/adc.2008.143594. Epub 2009 Feb 17.
4
Challenges and successes of a multidisciplinary pediatric obesity treatment program.一个多学科儿科肥胖治疗项目的挑战与成功
Nutr Clin Pract. 2014 Dec;29(6):780-5. doi: 10.1177/0884533614551839. Epub 2014 Oct 21.
5
Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement.非酒精性脂肪肝的生活方式干预:其疗效及改善相关因素的前瞻性队列研究。
Arch Dis Child. 2011 Jul;96(7):669-74. doi: 10.1136/adc.2010.199760. Epub 2011 Apr 25.
6
Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease.低 25-羟维生素 D 水平与非酒精性脂肪性肝病肥胖青少年的胰岛素敏感性相关。
Obes Res Clin Pract. 2013 Jul-Aug;7(4):e275-83. doi: 10.1016/j.orcp.2012.01.004.
7
Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.基于地中海生活方式的干预对非酒精性脂肪性肝病患者临床特征的改善:一项随机对照临床试验。
Br J Nutr. 2018 Jul;120(2):164-175. doi: 10.1017/S000711451800137X.
8
NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice.儿童非酒精性脂肪性肝病:一项前瞻性临床病理研究及生活方式建议的效果
Hepatology. 2006 Aug;44(2):458-65. doi: 10.1002/hep.21262.
9
Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children.10 周减肥营对肥胖丹麦儿童脂肪肝和胰岛素敏感性的影响。
J Pediatr Gastroenterol Nutr. 2012 Feb;54(2):223-8. doi: 10.1097/MPG.0b013e31822cdedf.
10
A meal high in saturated fat evokes postprandial dyslipemia, hyperinsulinemia, and altered lipoprotein expression in obese children with and without nonalcoholic fatty liver disease.富含饱和脂肪的膳食会引起肥胖伴有或不伴有非酒精性脂肪肝疾病儿童的餐后血脂异常、高胰岛素血症和脂蛋白表达改变。
JPEN J Parenter Enteral Nutr. 2013 Jul;37(4):517-28. doi: 10.1177/0148607112467820. Epub 2012 Dec 5.

引用本文的文献

1
Overview of Metabolic Dysfunction-Associated Steatohepatitis in Children.儿童代谢功能障碍相关脂肪性肝炎概述
Gastroenterol Hepatol (N Y). 2025 Apr;21(4):255-258.
2
Challenges and needs in the management of non-alcoholic fatty liver disease from the perspective of gastroenterology and hepatology specialists: a qualitative study.从胃肠病学和肝病学专家角度看非酒精性脂肪性肝病管理中的挑战与需求:一项定性研究
BMC Gastroenterol. 2025 May 22;25(1):396. doi: 10.1186/s12876-025-03921-z.
3
Longitudinal response to standard of care in pediatric metabolic dysfunction-associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomes.儿童代谢功能障碍相关脂肪性肝病对标准治疗的纵向反应:改善和恶化率以及与预后相关的因素。
Hepatology. 2025 Jan 3. doi: 10.1097/HEP.0000000000001216.
4
Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?饮食、运动和补充剂:在儿童代谢功能障碍相关脂肪性肝病的管理中,它们各自扮演什么角色?
Endocrine. 2024 Sep;85(3):988-1006. doi: 10.1007/s12020-024-03783-7. Epub 2024 Mar 22.
5
TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者临床评估与管理的TASL实践指南。
Hepatol Forum. 2023 Mar 15;4(Suppl 1):1-32. doi: 10.14744/hf.2023.2023.0011. eCollection 2023.
6
Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention.营养可预防或促进非酒精性脂肪性肝病:干预的机会。
BMJ. 2023 Oct 9;383:e075179. doi: 10.1136/bmj-2023-075179.
7
Multiple beneficial effects of 1-year nutritional-behavioral intervention on anthropometric and metabolic parameters in overweight and obese boys.1 年营养-行为干预对超重和肥胖男孩人体测量和代谢参数的多种有益影响。
J Endocrinol Invest. 2023 Nov;46(11):2331-2342. doi: 10.1007/s40618-023-02088-2. Epub 2023 Apr 18.
8
Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges.儿童脂肪性肝病(MAFLD/PeFLD 2型):独特的分类考量与挑战
Ther Adv Endocrinol Metab. 2023 Mar 22;14:20420188231160388. doi: 10.1177/20420188231160388. eCollection 2023.
9
Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease.非肥胖非酒精性脂肪性肝病患者及高危人群的生活方式干预。
Diabetes Metab J. 2022 May;46(3):391-401. doi: 10.4093/dmj.2022.0048. Epub 2022 May 25.
10
Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem.儿童代谢性脂肪肝病:一个日益严重的公共卫生问题。
Biomedicines. 2021 Dec 14;9(12):1915. doi: 10.3390/biomedicines9121915.

本文引用的文献

1
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.维生素E或二甲双胍治疗儿童和青少年非酒精性脂肪性肝病的效果:TONIC随机对照试验
JAMA. 2011 Apr 27;305(16):1659-68. doi: 10.1001/jama.2011.520.
2
Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement.非酒精性脂肪肝的生活方式干预:其疗效及改善相关因素的前瞻性队列研究。
Arch Dis Child. 2011 Jul;96(7):669-74. doi: 10.1136/adc.2010.199760. Epub 2011 Apr 25.
3
Liver fat change in obese children after a 1-year nutrition-behavior intervention.肥胖儿童经过 1 年营养-行为干预后的肝脏脂肪变化。
J Pediatr Gastroenterol Nutr. 2010 Sep;51(3):331-5. doi: 10.1097/MPG.0b013e3181d70468.
4
Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease.果糖摄入量增加与非酒精性脂肪性肝病患者肝纤维化严重程度相关。
Hepatology. 2010 Jun;51(6):1961-71. doi: 10.1002/hep.23535.
5
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.随机对照试验测试减肥对非酒精性脂肪性肝炎的影响。
Hepatology. 2010 Jan;51(1):121-9. doi: 10.1002/hep.23276.
6
Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.肥胖儿童非酒精性脂肪肝病的生活方式干预:2年随访研究。
Arch Dis Child. 2009 Jun;94(6):437-42. doi: 10.1136/adc.2008.143594. Epub 2009 Feb 17.
7
Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis.减肥手术对非酒精性脂肪性肝病的影响:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2008 Dec;6(12):1396-402. doi: 10.1016/j.cgh.2008.08.012. Epub 2008 Aug 19.
8
Bariatric surgery for extreme adolescent obesity: indications, outcomes, and physiologic effects on the gut-brain axis.极端青少年肥胖的减重手术:适应证、结局及对肠-脑轴的生理影响
Pathophysiology. 2008 Aug;15(2):135-46. doi: 10.1016/j.pathophys.2008.04.005. Epub 2008 Jun 27.
9
Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.非酒精性脂肪性肝病患儿的生活方式干预与抗氧化治疗:一项随机对照试验。
Hepatology. 2008 Jul;48(1):119-28. doi: 10.1002/hep.22336.
10
Bariatric surgery for morbid obesity.针对病态肥胖的减肥手术。
N Engl J Med. 2007 May 24;356(21):2176-83. doi: 10.1056/NEJMct067019.